Cytokines in breast cancer

A Nicolini, A Carpi, G Rossi - Cytokine & growth factor reviews, 2006 - Elsevier
In recent decades many advances have occurred in the understanding of the role of
cytokines in breast cancer. New signalling pathways of interleukin (IL)-1 family, IL-6, IL-11, IL …

Metastatic breast cancer: an updating

A Nicolini, R Giardino, A Carpi, P Ferrari… - Biomedicine & …, 2006 - Elsevier
This article reports on recent advances on metastatic breast cancer. Detection, prognostic
factors, predictors of response to therapy and therapy, with particular regard to targeted …

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

DF Hayes, M Cristofanilli, GT Budd, MJ Ellis… - Clinical Cancer …, 2006 - AACR
Purpose: We reported previously that≥ 5 circulating tumor cells (CTC) in 7.5 mL blood at
baseline and at first follow-up in 177 patients with metastatic breast cancer (MBC) were …

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

DJA Lobbezoo, RJW Van Kampen, AC Voogd… - British journal of …, 2015 - nature.com
Background: We aimed to determine the prognostic impact of time between primary breast
cancer and diagnosis of distant metastasis (metastatic-free interval, MFI) on the survival of …

[HTML][HTML] Prognostic factors in 1038 women with metastatic breast cancer

R Largillier, JM Ferrero, J Doyen, J Barriere, M Namer… - Annals of …, 2008 - Elsevier
Background: Treatment of metastatic breast cancer (MBC) remains palliative. Patients with
MBC represent a heterogeneous group whose prognosis and outcome may be dependent …

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

DJA Lobbezoo, RJW van Kampen, AC Voogd… - Breast cancer research …, 2013 - Springer
Contrary to the situation in early breast cancer, little is known about the prognostic relevance
of the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) in …

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer …

T Bachelot, I Ray-Coquard, C Menetrier-Caux… - British journal of …, 2003 - nature.com
Prediction of survival for patients with metastatic breast cancer is often inaccurate and may
be helped by new biological parameters. Tumour growth being angiogenesis-dependent, it …

Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer

X Liu, QH Meng, Y Ye, MAT Hildebrandt, J Gu… - …, 2015 - academic.oup.com
Liver function tests (LFTs) have been reported as independent predictors of non-liver
disease-related morbidity and mortality in general population and cancer patients. In this …

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

T Ueno, M Toi, M Koike, S Nakamura… - British journal of …, 2000 - nature.com
Tissue factor (TF), an initiator of the extrinsic coagulation cascade, is expressed in a wide
range of cancer cells and plays important roles in cancer progression and metastasis …

Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma

JL Gulley, PM Arlen, KY Tsang, J Yokokawa… - Clinical Cancer …, 2008 - AACR
Purpose: Poxviral vectors have a proven safety record and can be used to incorporate
multiple transgenes. Prior clinical trials with poxviral vaccines have shown that immunologic …